[Controlled attenuation parameter is a novel technique in screening for non-alcoholic fatty liver disease].

Non-alcoholic fatty liver disease afflicts 30% of the population and is tightly linked to the metabolic syndrome and development of cardiovascular disease and chronic liver disease. Regular ultrasound is currently used in liver steatosis diagnosing, but it is operator-dependent, fails to detect lower grades of steatosis, and is unable to graduate the degree of steatosis. Controlled attenuation parameter is a novel, ultrasound-based technique to accurately detect and grade steatosis. Further studies are needed to establish cut-offs, before it can be implemented in clinical practice.